Daniel Flynn
Founder at Deciphera Pharmaceuticals LLC
Net worth: 6 M $ as of 2024-03-30
Profile
Daniel L.
Flynn was the founder of Deciphera Pharmaceuticals, Inc. (founded in 2003) and held the title of Chief Scientific Officer & Executive VP from 2014 to 2023.
Dr. Flynn is also the founder of Deciphera Pharmaceuticals LLC.
Dr. Flynn's former job positions include Chairman-Medicinal Chemistry Division at the American Chemical Society, Director-Medicinal Chemistry at Amgen, Inc., Senior Director-Chemistry at Millennium Pharmaceuticals, Inc., Director-Medicinal Chemistry at Monsanto Co., Principal at Warner-Lambert Co., Principal at G.D.
Searle & Co., Inc., Principal at Parke-Davis Pharmaceutical Research, Inc., and Trustee at the University of Kansas Center for Research, Inc.Dr. Flynn's education history includes a doctorate degree from the University of Kansas, conferred in 1981, and an undergraduate degree from the University of Kansas.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-15 | 378,613 ( 0.47% ) | 6 M $ | 2024-03-30 |
Daniel Flynn active positions
| Companies | Position | Start |
|---|---|---|
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Founder | 2002-12-31 |
Former positions of Daniel Flynn
| Companies | Position | End |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Chief Executive Officer | 2014-02-28 |
| MONSANTO | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
University of Kansas Center for Research, Inc.
 University of Kansas Center for Research, Inc. Miscellaneous Commercial ServicesCommercial Services University of Kansas Center for Research, Inc. develops and administrates sponsored university programs. The not-for-profit research foundation submits proposals for external support of research, instructional, and service projects. It also provides contract negotiation, proposal and post-award, facility construction and development, resources investment, and financial management support services. The company was founded in 1962 and is headquartered in Lawrence, KS. | Director/Board Member | - |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Training of Daniel Flynn
| University of Kansas | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
| Parke-Davis Pharmaceutical Research, Inc. | |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
University of Kansas Center for Research, Inc.
University of Kansas Center for Research, Inc. Miscellaneous Commercial ServicesCommercial Services University of Kansas Center for Research, Inc. develops and administrates sponsored university programs. The not-for-profit research foundation submits proposals for external support of research, instructional, and service projects. It also provides contract negotiation, proposal and post-award, facility construction and development, resources investment, and financial management support services. The company was founded in 1962 and is headquartered in Lawrence, KS. | Commercial Services |
- Stock Market
- Insiders
- Daniel Flynn
